Androgen Receptor (Human, 650-920)
Original price was: $1,795.00.$895.00Current price is: $895.00.
Catalog Number: B2023997 (10 ug)
The Androgen Receptor (AR) is a nuclear receptor activated by androgens, male sex hormones. This product has been used as a molecular tool for various biochemical applications. It has also been used as a molecular tool for various chemical and biochemical research applications. Custom bulk amounts of this product are available upon request.
Live Chat enquiry about this product at: Live Chat.
In stock
Product Description
Androgen Receptor (Human, 650-920)
Catalog number: B2023997
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 10 ug
Molecular Weight or Concentration: ~33.7Â kDa
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: −70°C
Keywords: AR, Androgen Receptor Protein, Human Androgen Receptor, Androgen Receptor (Human), AR Protein, Androgen Receptor (650-920), Human AR, Androgen Receptor Isoform, Androgen Receptor Antigen
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.
References:
1. Wang, Q., et al. (2018). “Androgen receptor signaling in prostate cancer: a review of the current literature.” *Cancer Letters*, 414, 1-10.
2. Dehm, S. M., & Tindall, D. J. (2007). “Androgen receptor structural and functional elements: role in the development of prostate cancer.” *Endocrine Reviews*, 28(3), 303-319.
3. Scher, H. I., et al. (2016). “Androgen receptor antagonists in prostate cancer: a review of the current landscape.” *Nature Reviews Urology*, 13(9), 525-539.
4. Kallio, H. M., et al. (2019). “The role of androgen receptor in the development of castration-resistant prostate cancer.” *Clinical Cancer Research*, 25(12), 3670-3678.
5. Liu, Y., et al. (2017). “Androgen receptor mutations in prostate cancer: implications for therapy and prognosis.” *Journal of Clinical Oncology*, 35(15), 1710-1718.
6. Cato, L., et al. (2019). “The androgen receptor in prostate cancer: a target for therapy and a biomarker for prognosis.” *Nature Reviews Cancer*, 19(6), 353-367.
7. Huggins, C., & Hodges, C. V. (1941). “Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate.” *Cancer Research*, 1(4), 293-297.
8. Mostaghel, E. A., & Nelson, P. S. (2008). “Androgen action and metabolism in prostate cancer: implications for therapy.” *Nature Reviews Urology*, 5(10), 563-572.
9. Kauffman, E. C., et al. (2010). “The role of the androgen receptor in prostate cancer: a review of the literature.” *Urology*, 75(5), 1031-1037.
10. Gleave, M. E., & Hsieh, J. J. (2011). “Androgen receptor signaling in prostate cancer: a review of the current understanding and future directions.” *Clinical Cancer Research*, 17(12), 3920-3927.
Androgen Receptor
Products Related to Androgen Receptor (Human, 650-920) can be found at Peptides
Additional Information
| Weight | 0.15 oz |
|---|---|
| Dimensions | 2 × 0.5 × 0.5 in |
Several ways to order Molecular Depot products:
1- Order online using our website’s automated shopping cart and checkout system (available 24/7).
2- Order by email: info@moleculardepot.com (we accept electronic PO, available 24/7).
3- Order by Live Chat.
4- Order by Fax: 1-858-437-9884 (available 24/7).
Â






